Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report.

Background/aims: HIV and hepatitis C virus (HCV) share common modes of transmission, resulting in about 33% incidence of coinfection among people infected with HIV. The survival benefit from highly effective antiretroviral therapy (HAART) for HIV infection is resulting in an increased incidence of hepatocellular carcinoma (HCC) in this population. There are no reports to date regarding the coadministration of HAART and sorafenib for hepatocellular carcinoma.

Contribution of imaging to the evaluation of pyomyositis.

Purpose: To analyse the fundamental features of each imaging modality with the aim of defining their contribution to the diagnosis of pyomyositis.

Materials And Methods: We retrospectively reviewed 10 observations collected between 1997 and 2004, 5 of paravertebral muscles and 5 of the muscles of the limbs. Imaging was carried out with US (8/10 observations) and/or CT (9/10 observations), and/or MRI (6/10 observations).